Telo Genomics
Biotechnology company developing a proprietary telomere analysis platform for cancer and neurological disease insights.
Rate
About
Telo Genomics is a biotechnology company focused on developing and commercializing a proprietary telomere analysis platform. Their technology aims to provide novel insights into cancer and neurological diseases by analyzing telomere length and dynamics in biological samples.
Technology stack
detected 2026-06-10Est. monthly stack spend~$140/mo
Emailnone
Hosting
AWS
AWSComments
No comments yet. Be the first to share your take.
Frequently asked
What does Telo Genomics do?
Telo Genomics is a biotechnology company focused on developing and commercializing a proprietary telomere analysis platform. Their technology aims to provide novel insights into cancer and neurological diseases by analyzing telomere length and dynamics in biological samples.
Where is Telo Genomics headquartered?
Telo Genomics is headquartered in Toronto, Canada.
When was Telo Genomics founded?
Telo Genomics was founded in 2014.
What industry does Telo Genomics operate in?
Telo Genomics operates in Biotech, MedTech, HealthTech, Genomics, Cancer Diagnostics, Neurological Disease Research.
What is Telo Genomics's current status?
Telo Genomics's current operating status is: Inactive.